Assignee
WESTLAKE THERAPEUTICS HANGZHOU CO LTD
CN·1 granted patent·5 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
6 records- 0148US2024228983A1Modified Red Blood Cells and Uses Thereof For Treating Hyperuricemia and GoutWESTLAKE THERAPEUTICS HANGZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0246US2025276013A1Cells Modified by Conjugated N-Terminal Glycine and Uses ThereofWESTLAKE THERAPEUTICS HANGZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0340US2023399616A1Modified Red Blood Cells and Uses Thereof for Delivering AgentsWESTLAKE THERAPEUTICS HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0438US12480092B2Method for preparing mature red blood cells in vitro using peripheral bloodWESTLAKE THERAPEUTICS HANGZHOU CO LTD·Filed 2020·Granted Nov 25, 2025·0 cites·10 claims
- 0538US2023145118A1Modified Red Blood Cells and Uses Thereof for Delivering AgentsWESTLAKE THERAPEUTICS HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0634US2024043802A1Genetically engineered erythrocytes carrying anti-pd-1 single chain antibody and preparation method thereforWESTLAKE THERAPEUTICS HANGZHOU CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when WESTLAKE THERAPEUTICS HANGZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →